10 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... - Strong Medicine ... #comparison #management ... endocrinology #dm2
Effects of Strokes by Location - Anterior vs Posterior Localization

Anterior Circulation 
 - MCA 
 -
Effects of Strokes ... Anterior vs Posterior Localization ... Basilar Artery #Strokes ... #Syndromes #CVA ... Neurology #Diagnosis #Table
Summary of All RCTs to Date on Endovascular Therapy for Acute Ischemic Stroke 

#EBM #Neurology #NeuroInterventionalRadiology
Summary of All RCTs ... Acute Ischemic Stroke ... EndovascularTherapy #Stroke ... #CVA #RCT #Summary ... #Table
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... #pharmacology #dm2 ... overview #management #comparison
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology Summary ... canagliflozin ↓ CV ... - Strong Medicine ... #Pharmacology #Summary ... #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... Ozempic), or daily tablet ... variety of adverse CV ... - Strong Medicine ... #DM2 #diabetes
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Summary of Coagulation ... Eric Strong @DrEricStrong ... - Strong Medicine ... #Deficiencies #Summary ... #table #comparison
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... Eric Strong @DrEricStrong ... - Strong Medicine ... #Pharmacology #Summary ... #DM2 #diabetes
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
b) CHF c) CVA ... Insulin dependent DM ... event, follow ACC algorithm ... Stable patients ... • <6mo since stroke
Fluid Responsiveness and Fluid Tolerance Testing - OnePager Summary
Fluid resuscitation can be beneficial when required or
Testing - OnePager Summary ... used to estimate stroke ... Venous Pressure (CVP ... ): Measures CVP ... #criticalcare #comparison